Medtech group OrganOx Ltd opens new HQ in Oxford
University of Oxford spinout and medtech group OrganOx Ltd has opened its new 18,000 sq ft global headquarters for research, development, and production in Oxford.
OrganOx, which was founded in 2008 and supported by Oxford University Innovation, has developed its lead product called the metra.
READ MORE: Oxford's OrganOx raises £25m to fuel expansion including US push
The device and its technology preserves donor livers at body temperature by circulating oxygenated blood and nutrients through them.
It was launched in Europe in 2018 and the US in 2022 and has quickly gained market adoption.
Craig Marshall, CEO of OrganOx, said: "Our new facility opening is a major milestone, providing OrganOx stakeholders access to world-class facilities and technologies as we work together in ways that were simply not possible previously.
"We are proud to be a growing member of the Oxford business and scientific community, and I am greatly looking forward to broader collaborations with commercial and clinical partners."
Professor Peter Friend, chief medical officer and co-founder of OrganOx, added: "We are all excited about what the future holds for OrganOx as we continue to push the scientific and clinical boundaries with technology-based solutions designed to improve the lives of patients experiencing acute or chronic organ failure.
"This remarkable new facility will support us in that mission for many years to come."
